echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > FDA approves Novo nordisk Fiasp (Mendon Insulin Injection) 100u/mL label extension

    FDA approves Novo nordisk Fiasp (Mendon Insulin Injection) 100u/mL label extension

    • Last Update: 2020-06-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    recently announced that the U.SFood andDrug(http://Administration http://
    (http:// has approved the Fiasp (Mendin insulin injection) 100u/mL label extensionFiasp is a quick-acting insulin that was approved by the FDA in 2017 to treat adult patients with diabetes with intravenous infusions or subcutaneous multiple injections (MDI) under the supervision ofMedical(http://professionalsFiasp is the first and only quick-acting insulin injection that does not have a pre-meal prescription, which is given before meals or within 20 minutes of starting the mealFiasp has a variety of dose options for multiple daily injections (MDI) and continuous subcutaneous insulin infusions:(1) 10mL small bottles for insulin pump or MDI;Fiasp is closer to the natural physiological insulin response after a meal without diabetics than conventional winter insulinTo date, Fiasp has been approved by the United States, the European Union, Canada, Australia, Switzerland and other markets for adult sesame and improved blood sugar control in adult patients with type 1 and type 2 diabetes
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.